Walgreens, Express Scripts at a contract impasse
The Walgreen Company said on Tuesday that it was willing to walk away from more than $5 billion in annual revenue because the pharmacy benefits manager Express Scripts did not pay it enough to fill prescriptions. If the companies do not settle their dispute, people whose prescription benefits are handled by Express Scripts will not be able to get their prescriptions filled at the biggest drugstore chain in the United States, and Walgreens will give up about 7% of its annual revenue. The announcement on Tuesday follows a similar contract fight a year ago between Walgreens and the CVS Caremark Corporation that was resolved less than two weeks after it became public. The impasse with Express Scripts overshadowed news that Walgreens' net income climbed 30% in its third quarter. Walgreens' stock fell $1.90, or 4.2%, to $43.28 a share. Express Scripts rose 20 cents to $54.99 a share. Walgreens, which has spent months negotiating a new contract with Express Scripts, said it would stop participating in Express Scripts' prescription plans starting Jan. 1.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Carondelet to Pay $35M to Settle Fraud Allegations
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- CA Powers Up $80M HIE to 'Create Value in the Data'
- 3 Traits Personality Assessments Can't Reveal